期刊文献+

冠心病慢性心力衰竭患者室性心律失常的临床治疗分析 被引量:6

Analysis of clinical treatment of ventricular arrhythmia in patients with chronic heart failure caused by coronary heart disease
下载PDF
导出
摘要 目的研究冠心病慢性心力衰竭患者室性心律失常患者的临床治疗资料,为后期治疗提供可靠的参考数据。方法选取我院2012年3月-2013年2月收治的180例冠心病慢性心力衰竭患者,随机把患者分为对照组及观察组各90例,对照组采用西药,观察组在对照组基础上加以中药联合治疗,分析对比两组患者用药后的临床疗效及不良反应。结果观察组疗效及不良反应均优于对照组,观察组总有效率为90%,而对照组总仅仅达到72.2%,组间总有效率比较,具有显著差异性。结论应用中西医结合治疗冠心病慢性心力衰竭并发室性心律失常,其临床疗效显著,可有效地控制心律失常,减少不良反应,是临床用药的好方法,值得临床上大力推广。 Objective To study the clinical treatment data on ventricular arrhythmia (VA) in patients with chronic heart failure (CHF) caused by coronary heart disease (CHD) and to provide a reliable reference for posttreatment. Methods A total of 180 patients with CHF caused by CHD who were admitted to our hospital from March 2012 to February 2013 were randomly divided into control group (n=90) and observation group (n=90). The control group received Western medicine treatment, while the observation group received integrated traditional Chinese and Western medicine therapy. The two groups were compared in terms of clinical outcome and adverse events. Results The observation group was superior to the control group in terms of clinical outcome and adverse events; the observation group had a significantly higher overall response rate than the control group (90% vs 72.2%). Conclusion Integrated traditional Chinese and Western medicine therapy has good clinical efficacy in the treatment of VA in patients with CHF caused by CHD for it can effectively control arrhythmia and reduce adverse events. It holds promise for clinical application.
作者 李江温
出处 《心血管病防治知识(学术版)》 2013年第12期19-21,共3页 Prevention and Treatment of Cardiovascular Disease
关键词 冠心病慢性心力衰竭 室性心律失常 中西医结合 临床疗效 Chronic heart failure caused by coronary heart disease Ventricular arrhythmia Integrated traditional Chinese and Western medicine therapy Clinical efficacy
  • 相关文献

参考文献7

二级参考文献25

  • 1郭林妮,黄元铸,蒋文平,李庚山,陆再英,戚文航,任自文,吴宁,向晋涛,朱俊,方圻,高润霖.胺碘酮抗心律失常治疗应用指南[J].中国心脏起搏与心电生理杂志,2004,18(6):401-407. 被引量:392
  • 2蒋文平.胺碘酮抗心律失常治疗应用指南[J].中华心血管病杂志,2004,32(12):1065-1071. 被引量:142
  • 3Exner DV,Reiffel JA,Epstein AE,et al.Beta-blocker use and sur-vival in patient with ventricular fibrillation or symptomatic ventricular tachycardia:the Antiarrythmics versus Imlantable Defibrillators(AVID)trial[J].J Am Col Caudiol,1999;34(5):325-333.
  • 4Ashrafian H, Frenneaux MP, Opie LH. Metabolic mechanisms inheart failure [ J]. Circulation ,2007,116:434 - 448.
  • 5Virmani A, Gaetani F, Imam S, et, al. The protective role of L-carnitine against neurotoxicity evoked by drug of abuse, methamphet-amine,could be related to mitochondrial dysfunction [ J ]. Ann NY Acad sei ,2002,965:225 - 232.
  • 6Stewart S, Mac IK, Apewe!.I S,et al. Heart {allure and the aging populationAn increasing burden in the 21st century[J]. Heart, 2003,89(1) :49 - 53.
  • 7陈勇,向琳,胡玉华,等.参松养心胶囊联合胺碘酮治疗充血性心力衰竭室性心律失常的疗效及安全性观察[J].中医结合心脑血管病杂志,2011,9(9):1047-1048.
  • 8Remme WJ. Bata blockers or angiotension - converting - enzyme inhibitor/angiotension receptor blocker What shoud be first[J]. Cardiol Clin, 2007,25 581 - 594.
  • 9CIBIS - II investigators and committecs. The cardiac insufficiency bisoprolol study II (CIBIS II ) a randomised trial[J] Lancet, 1999, 353(9146) :9 - 13.
  • 10无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3671

共引文献228

同被引文献33

引证文献6

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部